Sosman J - Search Results

1

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".

Ascierto PA, Grimaldi AM, Acquavella N, Borgognoni L, Calabrò L, Cascinelli N, Cesano A, Del Vecchio M, Eggermont AM, Faries M, Ferrone S, Fox BA, Gajewski TF, Galon J, Gnjatic S, Gogas H, Kashani-Sabet M, Kaufman HL, Larkin J, Lo RS, Mantovani A, Margolin K, Melief C, McArthur G, Palmieri G, Puzanov I, Ribas A, Seliger B, Sosman J, Suenaert P, Tarhini AA, Trinchieri G, Vidal-Vanaclocha F, Wang E, Ciliberto G, Mozzillo N, Marincola FM, Thurin M. Ascierto PA, et al. Among authors: sosman j. J Transl Med. 2013 Jun 3;11:137. doi: 10.1186/1479-5876-11-137. J Transl Med. 2013. PMID: 23731854 Free PMC article.

2

Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma.

Gajewski TF, Sosman J, Gerson SL, Liu L, Dolan E, Lin S, Vokes EE. Gajewski TF, et al. Among authors: sosman j. Clin Cancer Res. 2005 Nov 1;11(21):7861-5. doi: 10.1158/1078-0432.CCR-05-0060. Clin Cancer Res. 2005. PMID: 16278409 Clinical Trial.

3

Innovations and challenges in melanoma: summary statement from the first Cambridge conference.

Atkins MB, Elder DE, Essner R, Flaherty KT, Gajewski TF, Haluska FG, Hwu P, Keilholz U, Kirkwood JM, Mier JW, Ross MI, Slingluff CL, Sondak VK, Sosman JA, Weinstock MA, King L. Atkins MB, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2291s-2296s. doi: 10.1158/1078-0432.CCR-05-2560. Clin Cancer Res. 2006. PMID: 16609047

4

Molecular targets in melanoma from angiogenesis to apoptosis.

Sosman JA, Puzanov I. Sosman JA, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2376s-2383s. doi: 10.1158/1078-0432.CCR-05-2558. Clin Cancer Res. 2006. PMID: 16609062 Review.

5

Opportunities and obstacles to combination targeted therapy in renal cell cancer.

Sosman JA, Puzanov I, Atkins MB. Sosman JA, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 2):764s-769s. doi: 10.1158/1078-0432.CCR-06-1975. Clin Cancer Res. 2007. PMID: 17255307 Review.

6

Phase I/II trial of tremelimumab in patients with metastatic melanoma.

Camacho LH, Antonia S, Sosman J, Kirkwood JM, Gajewski TF, Redman B, Pavlov D, Bulanhagui C, Bozon VA, Gomez-Navarro J, Ribas A. Camacho LH, et al. Among authors: sosman j. J Clin Oncol. 2009 Mar 1;27(7):1075-81. doi: 10.1200/JCO.2008.19.2435. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139427 Clinical Trial.

7

Combination targeted therapy in advanced renal cell carcinoma.

Sosman J, Puzanov I. Sosman J, et al. Cancer. 2009 May 15;115(10 Suppl):2368-75. doi: 10.1002/cncr.24234. Cancer. 2009. PMID: 19402058 Free article. Review.

8

Inside life of melanoma cell signaling, molecular insights, and therapeutic targets.

Sosman JA, Margolin KA. Sosman JA, et al. Curr Oncol Rep. 2009 Sep;11(5):405-11. doi: 10.1007/s11912-009-0054-y. Curr Oncol Rep. 2009. PMID: 19679016 Review.

9

B-RAF inhibitors: an evolving role in the therapy of malignant melanoma.

Shepherd C, Puzanov I, Sosman JA. Shepherd C, et al. Curr Oncol Rep. 2010 May;12(3):146-52. doi: 10.1007/s11912-010-0095-2. Curr Oncol Rep. 2010. PMID: 20425073 Review.

10

Inhibition of mutated, activated BRAF in metastatic melanoma.

Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB. Flaherty KT, et al. Among authors: sosman ja. N Engl J Med. 2010 Aug 26;363(9):809-19. doi: 10.1056/NEJMoa1002011. N Engl J Med. 2010. PMID: 20818844 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

436 results

Search Page